Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Potassium channel function in vascular disease.

C G Sobey1

  • 1Department of Pharmacology, The University of Melbourne, Parkville, Victoria, Australia. cg.sobey@unimelb.edu.au

Arteriosclerosis, Thrombosis, and Vascular Biology
|January 9, 2001
PubMed
Summary

Vascular potassium (K+) channel function is altered in cardiovascular diseases like hypertension and diabetes. Understanding these changes is key to developing new therapies for blood vessel tone regulation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inflammasome activity is essential for one kidney/deoxycorticosterone acetate/salt-induced hypertension in mice.

British journal of pharmacology·2015
Same author

NOX1 deficiency in apolipoprotein E-knockout mice is associated with elevated plasma lipids and enhanced atherosclerosis.

Free radical research·2014
Same author

IL-1β and IL-18: inflammatory markers or mediators of hypertension?

British journal of pharmacology·2014
Same author

Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke.

Cell death & disease·2013
Same author

Reduction of cerebral infarct volume by apocynin requires pretreatment and is absent in Nox2-deficient mice.

British journal of pharmacology·2009
Same author

Mechanisms of augmented vasoconstriction induced by 5-hydroxytryptamine in aortic rings from spontaneously hypertensive rats.

British journal of pharmacology·2008

Area of Science:

  • Cardiovascular Physiology
  • Molecular Biology
  • Pharmacology

Background:

  • Potassium ion (K+) channel activity regulates vascular muscle cell membrane potential (E(m)) and vascular tone.
  • Altered K+ channel function is implicated in cardiovascular diseases including hypertension, diabetes, and atherosclerosis.
  • Endothelial cell dysfunction and altered signaling molecules contribute to changes in vascular K+ channel activity.

Purpose of the Study:

  • To review the impact of cardiovascular diseases on vascular K+ channel function.
  • To highlight the role of K+ channels in regulating vascular tone and disease states.
  • To discuss current limitations and future directions in studying vascular K+ channel abnormalities.

Main Methods:

  • Review of existing literature on vascular K+ channel function in disease.

Related Experiment Videos

  • Analysis of data derived from pharmacological modulators of K+ channels.
  • Discussion of emerging molecular approaches like gene targeting in mice.

    • Main Results:

    • Cardiovascular diseases frequently alter vascular K+ channel function, leading to vasoconstriction and impaired vasodilation.
    • In some cases, enhanced K+ channel activity may serve a compensatory role against increased vascular tone.
    • Pharmacological modulation is the primary current method for assessing disease effects on K+ channels.

    Conclusions:

    • Specific K+ channel dysfunctions in vascular diseases are increasingly recognized.
    • Selective drugs and molecular techniques will enable precise identification of K+ channel abnormalities.
    • Identifying specific channel defects offers novel therapeutic strategies for vascular disorders.